The cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4% during the forecast period from 2017 to 2022.
Pharmaceutical and Biotechnological Companies are Expected to Account for the Largest Share of the Global Cell-Based Assays Market in 2017
MarketsandMarkets™ - Jul 10, 2017
